Accessibility Menu

3 No-Brainer Dividend Stocks to Buy Right Now

You don't need to settle for an average dividend yield.

By Patrick Sanders Dec 30, 2025 at 3:05PM EST

Key Points

  • AbbVie's major drugs, Skyrizi and Rinvoq, are generating lots of sales.
  • Realty Income's diversified portfolio provides plenty of protection and monthly income.
  • The JEPQ ETF employs a covered-call strategy on Nasdaq-100 stocks.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.